You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Stroke Shouldn't Be a Life Sentence.
At CERENOVUS, we are changing the trajectory of stroke.
Stroke is one of the most devastating diseases, robbing people of their independence and their quality of life.
1 in 6 people worldwide will have a stroke in their lifetime1
6 seconds worldwide, a stroke claims a life every 6 seconds1
Stroke remains the third leading cause of death in the world and a leading cause of long-term disability1
Neuravi Thromboembolic Initiative
The complex nature of clot can complicate therapeutic intervention.
No two occlusions are alike – clots that cause a stroke can have a variety of compositions and properties. The NTI is a commitment to advance the treatment of stroke through interdisciplinary collaboration and investment in clot and occlusion research.
Let’s change the TRAJECTORY of stroke. We are committed to pushing the boundaries of what is possible in stroke care.
News & Events
New CERENOVUS study demonstrates cost-savings associated with First-Pass Effect in mechanical thrombectomy for treating acute ischemic stroke in the US and Europe
CERENOVUS Launches Largest Global Registry to Study Stroke-Inducing Blood Clots Removed by Thrombectomy
1. World Stroke Organization World Stroke Campaign Web site. https://www.worldstrokecampaign.org/learn/the-facts-behind-1-in-6.html. Accessed December 18, 2018
© CERENOVUS 2021
This site is published by CERENOVUS which is solely responsible for its contents.
It is intended for visitors from the United States.
© CERENOVUS 2021 Last Updated on 4/14/2021.